| Literature DB >> 33350177 |
Hyunju Kim1, Min Ho Shin2, Suk Ja Yoon3, Sun Seog Kweon4,5, Young Hoon Lee6, Chang Kyun Choi4, OkJoon Kim7, Young Joon Kim1, HyunJu Chung1, Ok Su Kim8.
Abstract
PURPOSE: Vitamin D deficiency may cause bone loss and increased inflammation, which are well-known symptoms of periodontal disease. This study investigated whether serum 25-hydroxyvitamin D (25(OH)D) levels are associated with periodontal disease status and tooth loss.Entities:
Keywords: Cross-sectional studies; Periodontitis; Tooth loss; Vitamin D
Year: 2020 PMID: 33350177 PMCID: PMC7758301 DOI: 10.5051/jpis.2002540127
Source DB: PubMed Journal: J Periodontal Implant Sci ISSN: 2093-2278 Impact factor: 2.614
Figure 1Flowchart of the final study sample.
25(OH)D: 25-hydroxyvitamin D.
Demographic characteristics of study participants
| Characteristics | Total | Male | Female | ||
|---|---|---|---|---|---|
| No. | 5,405 | 2,253 | 3,152 | ||
| 25(OH)D (ng/mL) | 17.0±5.8 | 19.4±6.0 | 15.3±5.1 | <0.001 | |
| Age (yr) | 64.9±8.1 | 66.1±7.9 | 64.1±8.1 | <0.001 | |
| Education (middle school or less) | 2,031 (37.6) | 1,224 (54.3) | 807 (25.6) | <0.001 | |
| Body mass index (kg/m2) | 24.3±2.9 | 23.9±2.7 | 24.6±2.9 | <0.001 | |
| Current smoking status | 594 (11.0) | 541 (24.0) | 53 (1.7) | <0.001 | |
| Alcohol consumption status | 2,541 (47.0) | 1,525 (67.7) | 1,016 (32.2) | <0.001 | |
| Regular exercise | 1,915 (35.4) | 923 (41.0) | 992 (31.5) | <0.001 | |
| Antihypertensive medication | 1,937 (35.8) | 799 (35.5) | 1,138 (36.1) | 0.628 | |
| Antidiabetic medication | 702 (13.0) | 338 (15.0) | 364 (11.5) | <0.001 | |
| Month of blood collection | 0.282 | ||||
| April | 1,157 (21.4) | 505 (22.4) | 652 (20.7) | ||
| May | 1,899 (35.1) | 783 (34.8) | 1,116 (35.4) | ||
| June | 1,714 (31.7) | 717 (31.8) | 997 (31.6) | ||
| July | 635 (11.7) | 248 (11.0) | 387 (12.3) | ||
| No. of remaining teeth | 22.2±8.0 | 22.4±7.9 | 22.0±8.2 | 0.167 | |
| PPD 4% | 7.6±11.8 | 9.4±13.7 | 6.2±10.1 | <0.001 | |
| CAL 4% | 22.9±19.5 | 29.2±21.6 | 18.4±16.3 | <0.001 | |
| BOP% | 10.8±14.4 | 10.8±15.1 | 10.8±13.9 | 0.987 | |
| Severe periodontitisa) | 1,289 (25.1) | 772 (36.1) | 517 (17.3) | <0.001 | |
Data are presented as mean±standard deviation or number (%). P values were obtained using analysis of variance for continuous variables and the χ2 test for categorical variables.
25(OH)D: 25-hydroxyvitamin D, PPD 4%: the percentage of sites with probing depth ≥4 mm, CAL 4%: the percentage of sites with clinical attachment loss ≥4 mm, BOP%: the percentage of sites which bled after probing.
a)The severity of periodontitis was defined based on Centers for Disease Control/American Academy of Periodontology criteria. Fifty-one participants were not classified because of insufficient records.
Characteristics of study participants according to vitamin D status and sex
| Characteristics | Male | Female | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Severe deficiency | Deficiency | Insufficiency | Sufficiency | Severe deficiency | Deficiency | Insufficiency | Sufficiency | ||||
| No. | 51 (2.3) | 1,280 (56.8) | 799 (35.5) | 123 (5.5) | 299 (9.5) | 2,392 (75.9) | 413 (13.1) | 48 (1.5) | |||
| 25(OH)D (ng/mL) | 8.8±0.8 | 15.8±2.6 | 23.6±2.7 | 34.3±4.7 | <0.001 | 8.5±1.1 | 14.3±2.6 | 23.5±2.7 | 34.6±3.8 | <0.001 | |
| Age (yr) | 68.3±10.0 | 66.5±7.9 | 65.2±7.6 | 66.7±8.5 | 0.002 | 66.1±8.6 | 63.8±8.0 | 64.0±8.0 | 65.1±7.9 | <0.001 | |
| Education (middle school or less) | 18 (35.3) | 577 (45.1) | 362 (45.3) | 72 (58.5) | 0.014 | 244 (81.6) | 1,776 (74.2) | 300 (72.6) | 25 (52.1) | <0.001 | |
| Body mass index (kg/m2) | 22.3±2.9 | 23.9±2.8 | 24.0±2.6 | 23.3±2.4 | <0.001 | 24.4±2.9 | 24.6±3.0 | 24.5±2.7 | 24.0±2.8 | 0.216 | |
| Current smoking status | 21 (41.2) | 328 (25.6) | 169 (21.2) | 23 (18.7) | 0.001 | 13 (4.3) | 35 (1.5) | 5 (1.2) | 0 (0.0) | 0.002 | |
| Alcohol consumption status | 28 (54.9) | 822 (64.2) | 588 (73.6) | 87 (70.7) | <0.001 | 64 (21.4) | 795 (33.2) | 145 (35.1) | 12 (25.0) | <0.001 | |
| Regular exercise | 13 (25.5) | 536 (41.9) | 324 (40.6) | 50 (40.7) | 0.136 | 82 (27.4) | 752 (31.4) | 133 (32.2) | 25 (52.1) | 0.008 | |
| Antihypertensive medication | 15 (29.4) | 464 (36.2) | 279 (34.9) | 41 (33.3) | 0.680 | 122 (40.8) | 868 (36.3) | 128 (31.0) | 20 (41.7) | 0.042 | |
| Antidiabetic medication | 11 (21.6) | 203 (15.9) | 111 (13.9) | 13 (10.6) | 0.163 | 39 (13.0) | 287 (12.0) | 36 (8.7) | 2 (4.2) | 0.074 | |
| Month of blood collection | <0.001 | <0.001 | |||||||||
| April | 24 (47.1) | 348 (27.2) | 116 (14.5) | 17 (13.8) | 131 (43.8) | 459 (19.2) | 52 (12.6) | 10 (20.8) | |||
| May | 15 (29.4) | 486 (38.0) | 257 (32.2) | 25 (20.3) | 120 (40.1) | 862 (36.0) | 122 (29.5) | 12 (25.0) | |||
| June | 11 (21.6) | 343 (38.0) | 298 (37.3) | 65 (52.8) | 37 (12.4) | 776 (32.4) | 164 (39.7) | 20 (41.7) | |||
| July | 1 (2.0) | 103 (8.0) | 128 (16.0) | 16 (13.0) | 11 (3.7) | 295 (12.3) | 75 (18.2) | 6 (12.5) | |||
| No. of remaining teeth | 18.5±9.5 | 21.6±8.5 | 22.9±7.5 | 22.1±8.6 | <0.001 | 21.1±8.8 | 22.4±7.8 | 23.0±7.3 | 22.8±7.3 | 0.022 | |
| PPD 4% | 8.2±16.1 | 9.3±13.5 | 9.8±13.9 | 8.1±13.1 | 0.579 | 5.5±10.7 | 6.3±10.1 | 6.4±9.8 | 6.7±9.5 | 0.645 | |
| CAL 4% | 36.4±25.9 | 29.2±21.9 | 29.1±21.1 | 26.7±19.6 | 0.146 | 18.3±17 | 18.4±16.4 | 18.3±16.0 | 19.5±14.1 | 0.956 | |
| BOP% | 10.1±17.2 | 10.2±14.7 | 11.6±15.4 | 12.5±16.5 | 0.152 | 8.0±11.2 | 11.0±13.9 | 11.8±15.2 | 12.1±15.3 | <0.001 | |
| Severe periodontitisa) | 17 (37.0) | 450 (37.2) | 269 (35.1) | 36 (31.3) | 0.544 | 60 (21.7) | 382 (16.8) | 69 (17.4) | 6 (13.3) | 0.207 | |
Data are presented as mean±standard deviation or number (%).
P values were obtained using analysis of variance for continuous variables and the chi-square test for categorical variables.
25(OH)D: 25-hydroxyvitamin D, PPD 4%: the percentage of sites with probing depth ≥4 mm, CAL 4%: the percentage of sites with clinical attachment loss ≥4 mm, BOP%: the percentage of sites which bled after probing.
a)The severity of periodontitis was defined based on Centers for Disease Control/American Academy of Periodontology criteria. Fifty-one participants were not classified because of insufficient records.
Associations of vitamin D levels with number of remaining teeth and periodontal parameters
| Classification of serum vitamin D level (ng/mL) | Severe deficiency | Deficiency | Insufficiency | Sufficiency | ||
|---|---|---|---|---|---|---|
| Total | ||||||
| No. of teeth | 21.7±0.39 | 22.1±0.12 | 22.7±0.21 | 22.6±0.55 | 0.005 | |
| PPD 4%a) | 7.5±0.7 | 7.6±0.2 | 7.4±0.3 | 6.5±0.9 | 0.360 | |
| CAL 4%a) | 23.1±1.1 | 22.8±0.3 | 23.1±0.6 | 21.5±1.5 | 0.761 | |
| BOP%a) | 9.8±0.8 | 10.8±0.2 | 10.9±0.4 | 11.8±1.1 | 0.220 | |
| Male | ||||||
| No. of teeth | 20.3±1.1 | 21.9±0.2 | 22.4±0.3 | 22.4±0.7 | 0.046 | |
| PPD 4%a) | 8.8±2.0 | 9.7±0.4 | 9.4±0.5 | 7.5±1.2 | 0.247 | |
| CAL 4%a) | 35.3±3.2 | 29.0±0.6 | 29.5±0.8 | 26.6±2.0 | 0.309 | |
| BOP%a) | 11.9±2.2 | 10.7±0.4 | 10.9±0.5 | 11.3±1.4 | 0.820 | |
| Female | ||||||
| No. of teeth | 22.1±0.4 | 22.3±0.1 | 23.0±0.3 | 22.7±1.0 | 0.068 | |
| PPD 4%a) | 6.2±0.6 | 6.3±0.2 | 5.9±0.5 | 7.0±1.5 | 0.824 | |
| CAL 4%a) | 17.7±1.0 | 18.4±0.3 | 18.4±0.8 | 19.7±2.4 | 0.510 | |
| BOP%a) | 9.4±0.81 | 10.9±0.3 | 10.8±0.7 | 12.8±1.95 | 0.150 | |
Values are presented as adjusted mean±standard error of the mean. Values were estimated via linear regression analysis and adjusted for age, sex, month of blood collection, body mass index, smoking, alcohol consumption, regular exercise, antihypertensive medication, and antidiabetic medication.
PPD 4%: the percentage of sites with probing depth ≥4 mm, CAL 4%: the percentage of sites with clinical attachment loss ≥4 mm, BOP%: the percentage of sites which bled after probing.
a)A total of 228 edentulous participants were excluded from the analysis.
Odds ratios and 95% confidence intervals for severe periodontitis
| Classification of serum vitamin D level (ng/mL) | Severe deficiency | Deficiency | Insufficiency | Sufficiency |
|---|---|---|---|---|
| Total | 1.22 (0.92–1.61) | 1 (reference) | 0.96 (0.82–1.13) | 0.81 (0.55–1.17) |
| Male | 0.87 (0.46–1.61) | 1 (reference) | 0.90 (0.74–1.10) | 0.77 (0.50–1.16) |
| Female | 1.29 (0.93–1.76) | 1 (reference) | 1.04 (0.77–1.37) | 0.77 (0.29–1.71) |
All models were adjusted for age, sex, month of blood collection, body mass index, smoking status, alcohol consumption status, regular exercise, antihypertensive medication, and antidiabetic medication.
In total, 228 edentulous participants and 51 participants without sufficient records were excluded from the analysis.